Drug Type Small molecule drug |
Synonyms |
Mechanism AXL inhibitors(AXL receptor tyrosine kinase inhibitors), CSF-1R antagonists(Colony stimulating factor 1 receptor antagonists), DDR1 antagonists(Discoidin domain receptor 1 antagonists) + [3] |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Angex Pharmaceutical, Inc.Startup |
Active Organization- |
Inactive Organization Angex Pharmaceutical, Inc.Startup |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatocellular Carcinoma | Preclinical | US | Angex Pharmaceutical, Inc.Startup | 15 Aug 2020 |